Dataset | Score | p-value 1 | p-value 2 | p-value 3 |
---|---|---|---|---|
chia-screen-data-Fav | 2.944 | 1.07e-16 | 1.24e-04 | 1.29e-03 |
Gene Symbol | Entrez Gene ID | Frequency | chia-screen-data-Fav gene score | Best subnetwork score | Degree | Chia-Hits Primary | Chia-Hits Secondary |
---|---|---|---|---|---|---|---|
[ PRRX2 ] | 51450 | 1 | -1.316 | 2.944 | 9 | - | - |
HCFC1 | 3054 | 40 | -2.925 | 3.449 | 71 | Yes | Yes |
YAP1 | 10413 | 94 | -4.256 | 3.538 | 53 | Yes | - |
SOX10 | 6663 | 2 | -1.490 | 3.050 | 33 | - | - |
SRSF3 | 6428 | 73 | -2.992 | 3.538 | 54 | Yes | - |
NFRKB | 4798 | 48 | -3.129 | 3.108 | 23 | Yes | Yes |
POU5F1 | 5460 | 133 | -5.148 | 3.538 | 179 | Yes | Yes |
HNRNPU | 3192 | 76 | -2.869 | 3.538 | 139 | Yes | - |
SON | 6651 | 9 | -3.844 | 3.108 | 9 | Yes | Yes |
CDK12 | 51755 | 6 | -2.714 | 2.944 | 15 | Yes | - |
SUMO1 | 7341 | 7 | -1.696 | 3.050 | 439 | - | - |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
NFRKB | 4798 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
SUMO1 | 7341 | CDK12 | 51755 | pp | -- | int.I2D: BioGrid |
HNRNPU | 3192 | YAP1 | 10413 | pp | -- | int.I2D: HPRD; int.HPRD: in vitro, in vivo |
POU5F1 | 5460 | SOX10 | 6663 | pp | -- | int.I2D: HPRD, BCI; int.Ravasi: -; int.HPRD: in vitro |
HCFC1 | 3054 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
HNRNPU | 3192 | SUMO1 | 7341 | pp | -- | int.I2D: BioGrid |
SON | 6651 | SUMO1 | 7341 | pp | -- | int.I2D: BioGrid |
SOX10 | 6663 | PRRX2 | 51450 | pp | -- | int.I2D: HPRD; int.Ravasi: -; int.HPRD: yeast 2-hybrid |
SOX10 | 6663 | SUMO1 | 7341 | pp | -- | int.I2D: BCI, HPRD, MINT; int.Mint: MI:0566(sumoylation reaction); int.HPRD: in vivo |
POU5F1 | 5460 | SRSF3 | 6428 | pp | -- | int.I2D: BioGrid |
HNRNPU | 3192 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
POU5F1 | 5460 | SUMO1 | 7341 | pp | -- | int.I2D: BioGrid, BioGrid_Mouse |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0016607 | nuclear speck | 6.04e-06 | 8.71e-02 | 4.930 | 4 | 12 | 172 |
GO:0006366 | transcription from RNA polymerase II promoter | 8.08e-06 | 1.17e-01 | 3.968 | 5 | 30 | 419 |
GO:0008380 | RNA splicing | 1.84e-05 | 2.65e-01 | 4.524 | 4 | 22 | 228 |
GO:0005654 | nucleoplasm | 5.85e-05 | 8.43e-01 | 2.862 | 6 | 64 | 1082 |
GO:0005634 | nucleus | 7.76e-05 | 1.00e+00 | 1.524 | 10 | 159 | 4559 |
GO:0006355 | regulation of transcription, DNA-templated | 5.08e-04 | 1.00e+00 | 2.717 | 5 | 43 | 997 |
GO:0003713 | transcription coactivator activity | 6.56e-04 | 1.00e+00 | 4.053 | 3 | 24 | 237 |
GO:0044822 | poly(A) RNA binding | 6.63e-04 | 1.00e+00 | 2.634 | 5 | 50 | 1056 |
GO:0008134 | transcription factor binding | 6.97e-04 | 1.00e+00 | 4.023 | 3 | 18 | 242 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0005515 | protein binding | 1.10e-03 | 1.00e+00 | 1.122 | 10 | 198 | 6024 |
GO:0060242 | contact inhibition | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0019046 | release from viral latency | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 2 | 2 |
GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0090204 | protein localization to nuclear pore | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0031315 | extrinsic component of mitochondrial outer membrane | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0002944 | cyclin K-CDK12 complex | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0014015 | positive regulation of gliogenesis | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0009653 | anatomical structure morphogenesis | 1.74e-03 | 1.00e+00 | 4.982 | 2 | 2 | 83 |
GO:0003723 | RNA binding | 1.89e-03 | 1.00e+00 | 3.524 | 3 | 18 | 342 |
GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex | 2.29e-03 | 1.00e+00 | 8.772 | 1 | 1 | 3 |
GO:0060913 | cardiac cell fate determination | 2.29e-03 | 1.00e+00 | 8.772 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 2.29e-03 | 1.00e+00 | 8.772 | 1 | 1 | 3 |
GO:0001650 | fibrillar center | 2.29e-03 | 1.00e+00 | 8.772 | 1 | 1 | 3 |
GO:0051726 | regulation of cell cycle | 2.37e-03 | 1.00e+00 | 4.757 | 2 | 5 | 97 |
GO:0030578 | PML body organization | 3.05e-03 | 1.00e+00 | 8.357 | 1 | 1 | 4 |
GO:0070461 | SAGA-type complex | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 2 | 5 |
GO:0001714 | endodermal cell fate specification | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 2 | 5 |
GO:0043405 | regulation of MAP kinase activity | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 1 | 5 |
GO:0050733 | RS domain binding | 4.57e-03 | 1.00e+00 | 7.772 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 4.57e-03 | 1.00e+00 | 7.772 | 1 | 3 | 6 |
GO:0005730 | nucleolus | 4.85e-03 | 1.00e+00 | 1.998 | 5 | 66 | 1641 |
GO:0070688 | MLL5-L complex | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 1 | 8 |
GO:0043254 | regulation of protein complex assembly | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 1 | 8 |
GO:0006397 | mRNA processing | 6.30e-03 | 1.00e+00 | 4.035 | 2 | 10 | 160 |
GO:0000398 | mRNA splicing, via spliceosome | 6.61e-03 | 1.00e+00 | 3.999 | 2 | 15 | 164 |
GO:0043995 | histone acetyltransferase activity (H4-K5 specific) | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 5 | 9 |
GO:0046972 | histone acetyltransferase activity (H4-K16 specific) | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 5 | 9 |
GO:0048188 | Set1C/COMPASS complex | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 4 | 9 |
GO:0043996 | histone acetyltransferase activity (H4-K8 specific) | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 5 | 9 |
GO:0044212 | transcription regulatory region DNA binding | 6.92e-03 | 1.00e+00 | 3.964 | 2 | 17 | 168 |
GO:0035413 | positive regulation of catenin import into nucleus | 7.60e-03 | 1.00e+00 | 7.035 | 1 | 2 | 10 |
GO:0048484 | enteric nervous system development | 7.60e-03 | 1.00e+00 | 7.035 | 1 | 1 | 10 |
GO:0031625 | ubiquitin protein ligase binding | 7.74e-03 | 1.00e+00 | 3.881 | 2 | 5 | 178 |
GO:0019789 | SUMO ligase activity | 8.36e-03 | 1.00e+00 | 6.897 | 1 | 1 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 8.36e-03 | 1.00e+00 | 6.897 | 1 | 4 | 11 |
GO:0035198 | miRNA binding | 9.12e-03 | 1.00e+00 | 6.772 | 1 | 1 | 12 |
GO:0071480 | cellular response to gamma radiation | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 1 | 13 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 2 | 13 |
GO:0031334 | positive regulation of protein complex assembly | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 2 | 13 |
GO:0003677 | DNA binding | 1.03e-02 | 1.00e+00 | 2.106 | 4 | 49 | 1218 |
GO:0048546 | digestive tract morphogenesis | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 1 | 14 |
GO:0031011 | Ino80 complex | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 6 | 14 |
GO:0043981 | histone H4-K5 acetylation | 1.14e-02 | 1.00e+00 | 6.450 | 1 | 5 | 15 |
GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex | 1.14e-02 | 1.00e+00 | 6.450 | 1 | 3 | 15 |
GO:0001824 | blastocyst development | 1.14e-02 | 1.00e+00 | 6.450 | 1 | 2 | 15 |
GO:0043982 | histone H4-K8 acetylation | 1.14e-02 | 1.00e+00 | 6.450 | 1 | 5 | 15 |
GO:0043274 | phospholipase binding | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 1 | 16 |
GO:0060334 | regulation of interferon-gamma-mediated signaling pathway | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 1 | 16 |
GO:0001190 | RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 2 | 16 |
GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 1 | 16 |
GO:0010467 | gene expression | 1.24e-02 | 1.00e+00 | 2.556 | 3 | 45 | 669 |
GO:0030332 | cyclin binding | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 1 | 18 |
GO:0002052 | positive regulation of neuroblast proliferation | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 1 | 18 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 1.40e-02 | 1.00e+00 | 2.492 | 3 | 39 | 699 |
GO:0043984 | histone H4-K16 acetylation | 1.44e-02 | 1.00e+00 | 6.109 | 1 | 5 | 19 |
GO:0030318 | melanocyte differentiation | 1.44e-02 | 1.00e+00 | 6.109 | 1 | 3 | 19 |
GO:0042474 | middle ear morphogenesis | 1.59e-02 | 1.00e+00 | 5.964 | 1 | 1 | 21 |
GO:0048844 | artery morphogenesis | 1.59e-02 | 1.00e+00 | 5.964 | 1 | 1 | 21 |
GO:0000123 | histone acetyltransferase complex | 1.59e-02 | 1.00e+00 | 5.964 | 1 | 6 | 21 |
GO:0006281 | DNA repair | 1.61e-02 | 1.00e+00 | 3.329 | 2 | 14 | 261 |
GO:0045787 | positive regulation of cell cycle | 1.67e-02 | 1.00e+00 | 5.897 | 1 | 2 | 22 |
GO:0043484 | regulation of RNA splicing | 1.67e-02 | 1.00e+00 | 5.897 | 1 | 1 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.67e-02 | 1.00e+00 | 5.897 | 1 | 2 | 22 |
GO:0001205 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 1.67e-02 | 1.00e+00 | 5.897 | 1 | 4 | 22 |
GO:0048709 | oligodendrocyte differentiation | 1.74e-02 | 1.00e+00 | 5.833 | 1 | 2 | 23 |
GO:0045880 | positive regulation of smoothened signaling pathway | 1.74e-02 | 1.00e+00 | 5.833 | 1 | 1 | 23 |
GO:0007422 | peripheral nervous system development | 1.89e-02 | 1.00e+00 | 5.713 | 1 | 2 | 25 |
GO:0016925 | protein sumoylation | 1.89e-02 | 1.00e+00 | 5.713 | 1 | 2 | 25 |
GO:0048589 | developmental growth | 1.89e-02 | 1.00e+00 | 5.713 | 1 | 2 | 25 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 1.93e-02 | 1.00e+00 | 2.318 | 3 | 41 | 789 |
GO:0043392 | negative regulation of DNA binding | 1.97e-02 | 1.00e+00 | 5.656 | 1 | 4 | 26 |
GO:0035329 | hippo signaling | 1.97e-02 | 1.00e+00 | 5.656 | 1 | 5 | 26 |
GO:0048701 | embryonic cranial skeleton morphogenesis | 2.04e-02 | 1.00e+00 | 5.602 | 1 | 1 | 27 |
GO:0071339 | MLL1 complex | 2.04e-02 | 1.00e+00 | 5.602 | 1 | 6 | 27 |
GO:0001755 | neural crest cell migration | 2.12e-02 | 1.00e+00 | 5.549 | 1 | 1 | 28 |
GO:0004693 | cyclin-dependent protein serine/threonine kinase activity | 2.34e-02 | 1.00e+00 | 5.402 | 1 | 1 | 31 |
GO:0002053 | positive regulation of mesenchymal cell proliferation | 2.41e-02 | 1.00e+00 | 5.357 | 1 | 1 | 32 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 2.41e-02 | 1.00e+00 | 5.357 | 1 | 2 | 32 |
GO:0003682 | chromatin binding | 2.46e-02 | 1.00e+00 | 3.004 | 2 | 19 | 327 |
GO:0043565 | sequence-specific DNA binding | 2.74e-02 | 1.00e+00 | 2.922 | 2 | 11 | 346 |
GO:0032880 | regulation of protein localization | 2.79e-02 | 1.00e+00 | 5.147 | 1 | 2 | 37 |
GO:0030326 | embryonic limb morphogenesis | 2.79e-02 | 1.00e+00 | 5.147 | 1 | 1 | 37 |
GO:0048469 | cell maturation | 2.86e-02 | 1.00e+00 | 5.109 | 1 | 1 | 38 |
GO:0035019 | somatic stem cell maintenance | 3.01e-02 | 1.00e+00 | 5.035 | 1 | 6 | 40 |
GO:0031124 | mRNA 3'-end processing | 3.16e-02 | 1.00e+00 | 4.964 | 1 | 2 | 42 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 3.31e-02 | 1.00e+00 | 4.897 | 1 | 3 | 44 |
GO:0006369 | termination of RNA polymerase II transcription | 3.38e-02 | 1.00e+00 | 4.865 | 1 | 2 | 45 |
GO:0042472 | inner ear morphogenesis | 3.75e-02 | 1.00e+00 | 4.713 | 1 | 2 | 50 |
GO:0045892 | negative regulation of transcription, DNA-templated | 3.79e-02 | 1.00e+00 | 2.667 | 2 | 24 | 413 |
GO:0000910 | cytokinesis | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 2 | 51 |
GO:0000226 | microtubule cytoskeleton organization | 3.90e-02 | 1.00e+00 | 4.656 | 1 | 2 | 52 |
GO:0009611 | response to wounding | 3.90e-02 | 1.00e+00 | 4.656 | 1 | 5 | 52 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 3.97e-02 | 1.00e+00 | 4.629 | 1 | 5 | 53 |
GO:0043066 | negative regulation of apoptotic process | 3.98e-02 | 1.00e+00 | 2.629 | 2 | 16 | 424 |
GO:0051216 | cartilage development | 4.12e-02 | 1.00e+00 | 4.575 | 1 | 1 | 55 |
GO:0005643 | nuclear pore | 4.26e-02 | 1.00e+00 | 4.524 | 1 | 11 | 57 |
GO:0006396 | RNA processing | 4.41e-02 | 1.00e+00 | 4.474 | 1 | 5 | 59 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 4.41e-02 | 1.00e+00 | 4.474 | 1 | 6 | 59 |
GO:0003705 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity | 4.56e-02 | 1.00e+00 | 4.426 | 1 | 4 | 61 |
GO:0006406 | mRNA export from nucleus | 4.56e-02 | 1.00e+00 | 4.426 | 1 | 4 | 61 |
GO:0060333 | interferon-gamma-mediated signaling pathway | 4.63e-02 | 1.00e+00 | 4.402 | 1 | 3 | 62 |
GO:0006310 | DNA recombination | 4.85e-02 | 1.00e+00 | 4.334 | 1 | 7 | 65 |
GO:0042802 | identical protein binding | 5.06e-02 | 1.00e+00 | 2.438 | 2 | 19 | 484 |
GO:0010468 | regulation of gene expression | 5.07e-02 | 1.00e+00 | 4.269 | 1 | 2 | 68 |
GO:0060021 | palate development | 5.36e-02 | 1.00e+00 | 4.187 | 1 | 1 | 72 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 5.50e-02 | 1.00e+00 | 4.147 | 1 | 4 | 74 |
GO:0002020 | protease binding | 5.50e-02 | 1.00e+00 | 4.147 | 1 | 6 | 74 |
GO:0071013 | catalytic step 2 spliceosome | 5.79e-02 | 1.00e+00 | 4.071 | 1 | 7 | 78 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 6.37e-02 | 1.00e+00 | 3.930 | 1 | 8 | 86 |
GO:0016605 | PML body | 6.51e-02 | 1.00e+00 | 3.897 | 1 | 3 | 88 |
GO:0050821 | protein stabilization | 6.51e-02 | 1.00e+00 | 3.897 | 1 | 3 | 88 |
GO:0001649 | osteoblast differentiation | 6.80e-02 | 1.00e+00 | 3.833 | 1 | 5 | 92 |
GO:0003676 | nucleic acid binding | 7.87e-02 | 1.00e+00 | 3.615 | 1 | 2 | 107 |
GO:0030529 | ribonucleoprotein complex | 8.22e-02 | 1.00e+00 | 3.549 | 1 | 5 | 112 |
GO:0006325 | chromatin organization | 8.64e-02 | 1.00e+00 | 3.474 | 1 | 12 | 118 |
GO:0045202 | synapse | 9.90e-02 | 1.00e+00 | 3.269 | 1 | 5 | 136 |
GO:0010628 | positive regulation of gene expression | 1.06e-01 | 1.00e+00 | 3.167 | 1 | 7 | 146 |
GO:0006974 | cellular response to DNA damage stimulus | 1.09e-01 | 1.00e+00 | 3.118 | 1 | 7 | 151 |
GO:0046777 | protein autophosphorylation | 1.14e-01 | 1.00e+00 | 3.053 | 1 | 4 | 158 |
GO:0043687 | post-translational protein modification | 1.17e-01 | 1.00e+00 | 3.017 | 1 | 5 | 162 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 1.19e-01 | 1.00e+00 | 2.990 | 1 | 12 | 165 |
GO:0031965 | nuclear membrane | 1.21e-01 | 1.00e+00 | 2.964 | 1 | 10 | 168 |
GO:0007049 | cell cycle | 1.25e-01 | 1.00e+00 | 2.914 | 1 | 6 | 174 |
GO:0005667 | transcription factor complex | 1.26e-01 | 1.00e+00 | 2.905 | 1 | 17 | 175 |
GO:0004672 | protein kinase activity | 1.27e-01 | 1.00e+00 | 2.889 | 1 | 3 | 177 |
GO:0003714 | transcription corepressor activity | 1.28e-01 | 1.00e+00 | 2.881 | 1 | 11 | 178 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.32e-01 | 1.00e+00 | 2.833 | 1 | 22 | 184 |
GO:0005737 | cytoplasm | 1.33e-01 | 1.00e+00 | 0.799 | 5 | 124 | 3767 |
GO:0001701 | in utero embryonic development | 1.43e-01 | 1.00e+00 | 2.706 | 1 | 8 | 201 |
GO:0019221 | cytokine-mediated signaling pathway | 1.56e-01 | 1.00e+00 | 2.569 | 1 | 8 | 221 |
GO:0030425 | dendrite | 1.62e-01 | 1.00e+00 | 2.511 | 1 | 6 | 230 |
GO:0043025 | neuronal cell body | 1.72e-01 | 1.00e+00 | 2.420 | 1 | 9 | 245 |
GO:0000166 | nucleotide binding | 1.81e-01 | 1.00e+00 | 2.340 | 1 | 13 | 259 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 1.84e-01 | 1.00e+00 | 2.312 | 1 | 23 | 264 |
GO:0006954 | inflammatory response | 1.92e-01 | 1.00e+00 | 2.243 | 1 | 6 | 277 |
GO:0008283 | cell proliferation | 2.24e-01 | 1.00e+00 | 1.999 | 1 | 14 | 328 |
GO:0005524 | ATP binding | 2.60e-01 | 1.00e+00 | 1.015 | 2 | 31 | 1298 |
GO:0009986 | cell surface | 2.67e-01 | 1.00e+00 | 1.706 | 1 | 9 | 402 |
GO:0044267 | cellular protein metabolic process | 3.08e-01 | 1.00e+00 | 1.468 | 1 | 20 | 474 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 3.58e-01 | 1.00e+00 | 1.202 | 1 | 37 | 570 |
GO:0016020 | membrane | 3.73e-01 | 1.00e+00 | 0.642 | 2 | 46 | 1681 |
GO:0005739 | mitochondrion | 5.46e-01 | 1.00e+00 | 0.394 | 1 | 23 | 998 |
GO:0005829 | cytosol | 5.92e-01 | 1.00e+00 | 0.071 | 2 | 86 | 2496 |